JP2007529495A5 - - Google Patents

Download PDF

Info

Publication number
JP2007529495A5
JP2007529495A5 JP2007503427A JP2007503427A JP2007529495A5 JP 2007529495 A5 JP2007529495 A5 JP 2007529495A5 JP 2007503427 A JP2007503427 A JP 2007503427A JP 2007503427 A JP2007503427 A JP 2007503427A JP 2007529495 A5 JP2007529495 A5 JP 2007529495A5
Authority
JP
Japan
Prior art keywords
methyl
benzyl
piperazin
phenyl
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007503427A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007529495A (ja
JP4880583B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2005/000583 external-priority patent/WO2005090300A1/en
Publication of JP2007529495A publication Critical patent/JP2007529495A/ja
Publication of JP2007529495A5 publication Critical patent/JP2007529495A5/ja
Application granted granted Critical
Publication of JP4880583B2 publication Critical patent/JP4880583B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007503427A 2004-03-17 2005-03-07 新規なベンジル(ベンジリデン)−ラクタム誘導体 Expired - Fee Related JP4880583B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55380804P 2004-03-17 2004-03-17
US60/553,808 2004-03-17
PCT/IB2005/000583 WO2005090300A1 (en) 2004-03-17 2005-03-07 Novel benzyl(idene)-lactam derivatives

Publications (3)

Publication Number Publication Date
JP2007529495A JP2007529495A (ja) 2007-10-25
JP2007529495A5 true JP2007529495A5 (https=) 2008-04-24
JP4880583B2 JP4880583B2 (ja) 2012-02-22

Family

ID=34960867

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007503427A Expired - Fee Related JP4880583B2 (ja) 2004-03-17 2005-03-07 新規なベンジル(ベンジリデン)−ラクタム誘導体

Country Status (29)

Country Link
US (1) US7479559B2 (https=)
EP (1) EP1727794B1 (https=)
JP (1) JP4880583B2 (https=)
KR (1) KR20060124770A (https=)
CN (1) CN1934081A (https=)
AP (1) AP2006003726A0 (https=)
AR (1) AR050403A1 (https=)
AT (1) ATE533745T1 (https=)
AU (1) AU2005223481A1 (https=)
BR (1) BRPI0508825A (https=)
CA (1) CA2559530C (https=)
CR (1) CR8618A (https=)
DO (1) DOP2005000035A (https=)
EA (1) EA200601461A1 (https=)
EC (1) ECSP066853A (https=)
ES (1) ES2374629T3 (https=)
GT (1) GT200500051A (https=)
IL (1) IL178105A0 (https=)
MA (1) MA28474B1 (https=)
NL (1) NL1028558C2 (https=)
NO (1) NO20063602L (https=)
PA (1) PA8626501A1 (https=)
PE (1) PE20051153A1 (https=)
SV (1) SV2005002051A (https=)
TN (1) TNSN06287A1 (https=)
TW (1) TW200604165A (https=)
UY (1) UY28811A1 (https=)
WO (1) WO2005090300A1 (https=)
ZA (1) ZA200607133B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2371927T3 (es) * 2005-01-13 2012-01-11 Ge Healthcare Limited Compuestos de bencil-lactama marcados con 11c y su uso como agentes de obtención de imágenes.
WO2006136945A1 (en) * 2005-06-17 2006-12-28 Pfizer Products Inc. METABOLITES OF 1_ [_6- (1-ETHYL-l-HYDROXY-PROPYL) -PYRIDIN-3-YL] -3- [2- (4-METHYL-PIPERAZIN-I-YL) -BE NZYL] -PYRR0LIDIN-2-0NE AS SERATONIN RECEPTOR ANTAGONISTS
WO2007026219A2 (en) * 2005-08-31 2007-03-08 Pfizer Products Inc. Combinations of a 5-ht1b antagonist with a noradrenalin re-uptake inhibitor or a serotonin noradrenalin reutake inhibitor for treating cns conditions
WO2008068614A2 (en) * 2006-12-06 2008-06-12 Pfizer Products Inc. Stereoselective synthesis of 1-[6-ethyl-1,2-dihydroxy-propyl)-pyridin-3-yl]-3-[2-(4-methyl-piperazin-1-yl)-benzyl]-pyrrolidin-2-one
FR2948660B1 (fr) * 2009-07-30 2011-08-19 Oroxcell Derives de 2-amino-2-phenyl-alkanol, leur preparation et les compositions pharmaceutiques qui les contiennent
EP2338873A1 (en) 2009-12-22 2011-06-29 Gmeiner, Peter New aminotetraline derivatives
AU2010336027A1 (en) * 2009-12-23 2012-07-19 Auckland Uniservices Limited Compounds, preparations and uses thereof
WO2014028829A1 (en) 2012-08-16 2014-02-20 The Scripps Research Institute Novel kappa opioid ligands
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
KR101861942B1 (ko) * 2014-01-20 2018-06-29 에프. 호프만-라 로슈 아게 신경 발생을 자극할 수 있는 n-페닐-락탐 유도체 및 이의 신경 장애 치료에서의 용도
TW201706265A (zh) 2015-03-09 2017-02-16 必治妥美雅史谷比公司 做為Rho激酶(ROCK)抑制劑之內醯胺
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer
CN119219603A (zh) * 2023-06-28 2024-12-31 科辉智药(深圳)新药研究中心有限公司 Sarm1酶活性抑制剂及其用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58189163A (ja) * 1982-04-02 1983-11-04 Takeda Chem Ind Ltd 縮合ピロリノン誘導体
IL106142A (en) 1992-06-29 1997-03-18 Merck & Co Inc Morpholine and thiomorpholine tachykinin receptor antagonists, their preparation and pharmaceutical compositions containing them
DK0689536T3 (da) 1993-03-16 2001-07-30 Pfizer Naphthalenderivater
JP3786983B2 (ja) * 1994-01-27 2006-06-21 シエーリング アクチエンゲゼルシャフト ピロリジノン誘導体
GB9410512D0 (en) 1994-05-25 1994-07-13 Smithkline Beecham Plc Novel treatment
FI965238L (fi) 1994-06-29 1996-12-27 Pfizer Aryyli- ja heteroaryylialkoksinaftaleenijohdannaiset
EA001485B1 (ru) * 1996-03-29 2001-04-23 Пфайзер Инк. Производные бензил(иден)-лактамов, их получение и применение в качестве селективных (ант)агонистов рецепторов 5-htи/или 5-ht
US6423708B1 (en) * 1996-09-30 2002-07-23 Pfizer Inc Aralkyl and aralkylidene heterocyclic lactams and imides
UA56185C2 (uk) * 1996-09-30 2003-05-15 Пфайзер Інк. Аралкіл- та аралкіліденгетероциклічні лактами та іміди, фармацевтична композиція та спосіб лікування
DE10002509A1 (de) 2000-01-21 2001-07-26 Gruenenthal Gmbh Substituierte Glutarimide
US20020049211A1 (en) * 2000-09-06 2002-04-25 Sobolov-Jaynes Susan Beth Combination treatment for depression and anxiety
TWI263640B (en) * 2001-12-19 2006-10-11 Bristol Myers Squibb Co Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function

Similar Documents

Publication Publication Date Title
KR100524159B1 (ko) 모노아민 재흡수 억제제로서 유용한 비아릴 에테르 유도체
JP2007529495A5 (https=)
JP7453916B2 (ja) O-糖タンパク質-2-アセトアミド-2-デオキシ-3-d-グリコピラノシダーゼ阻害剤
JP7130873B2 (ja) バニン阻害剤としてのヘテロ芳香族化合物
AU2018287787A1 (en) Dihydro-pyrrolo-pyridine derivatives
KR101886945B1 (ko) 감마-세크레타제 조절제로서의 크로멘 및 1,1a,2,7b-테트라히드로시클로프로파[c]크로멘 피리도피라진디온
PT1353917E (pt) Novo processo de síntese de fenilamida do ácido 5-(4-fluorofenil)-1-[2-((2r,4r)-4-hidroxi-6-oxo-tetra-hidro-piran-2-il)-etil]-2-isopro-pil-4-fenil-1h-pirrole-3-carboxílico
JP2008526966A (ja) β−セクレターゼの阻害のためのアミノ−イミダゾロン
EA026668B1 (ru) Новые бициклические пиридиноны
JP2011519891A (ja) ヒスタミンh3受容体アンタゴニストとしてのアゼチジン類及びシクロブタン類
EA031614B1 (ru) Трициклические атропоизомерные соединения
JP6496246B2 (ja) アルドステロンシンターゼインヒビター関連用途としてのインドリン化合物
JP4880583B2 (ja) 新規なベンジル(ベンジリデン)−ラクタム誘導体
Firth et al. Revisiting the sparteine surrogate: development of a resolution route to the (−)-sparteine surrogate
KR101514505B1 (ko) Nk3 수용체 길항제로서 피롤리딘 유도체
EP2590963B1 (en) (3-methylpyrrolidin-3-yl)methyl pyridinyl ether derivatives and their use as nk-3 receptor antagonists
CN105102454A (zh) 作为cetp抑制剂的新型噁唑烷酮衍生物、其制备方法和包含其的药物组合物
JP2021505555A (ja) ベンゼン縮合複素環化合物およびその使用
HUP0003958A2 (hu) Eljárás 4-aril-piperidinek előállítására és az eljárásban alkalmazott intermedierek
DE69210675T2 (de) 3-Aryloxazolidinonderivate, Verfahren zu ihrer Herstellung und ihre Anwendung in der Heilkunde
AU2004289616B2 (en) Morpholine derivatives as norepinephrine reuptake inhibitors
JP2014508125A (ja) ジアステレオ異性有機化合物の製造方法
HK1242315A1 (en) Novel cyclopropabenzofuranyl pyridopyrazinediones
HK40027664A (en) Dihydro-pyrrolo-pyridine derivatives
HK1231481B (zh) 作为γ-分泌酶调节剂的色烯和1,1A,2,7B-四氢环丙烷并[C]色烯吡啶并吡嗪二酮